KOLINPHARMA®: “Growth Leader 2023" recognition obtained for the fifth consecutive year
This year, too, the company was confirmed among the 500 Italian companies that stood out for the highest revenue growth in the observation period between 2018 and 2021, with a revenue CAGR of 15.93%.
The study, a collaboration between Il Sole 24 Ore and Statista, analysed around 8,000 companies based in Italy, with revenue above €100,000 in 2018 and above €1.5 million in 2021, that stood out for high revenue growth rates, in terms of CAGR, achieved mainly through organic growth.
The full ranking is available online

















